問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital Hsin-Chu Branch
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2024-07-01 - 2027-11-30
Condition/Disease
Test Drug
Participate Sites4Sites
Recruiting4Sites
2019-03-06 - 2022-02-28
NSCLC
Telisotuzumab Vedotin (ABBV-399)
Participate Sites11Sites
Recruiting11Sites
2024-01-01 - 2026-12-31
Participate Sites6Sites
Not yet recruiting1Sites
Recruiting5Sites
2024-04-29 - 2027-03-01
Adenocarcinoma of Lung 、Carcinoma, Non-Small-Cell Lung
溶液劑
Participate Sites5Sites
2021-09-22 - 2033-12-31
Participate Sites14Sites
Recruiting14Sites
2023-12-31 - 2026-03-18
xxxxxx
Participate Sites8Sites
Recruiting8Sites
2022-08-01 - 2027-12-31
Participate Sites10Sites
Recruiting10Sites
2022-12-14 - 2026-12-31
Gout
錠劑
Participate Sites13Sites
Recruiting13Sites
2025-09-26 - 2029-12-03
Participate Sites2Sites
Recruiting2Sites
2023-08-01 - 2036-12-31
全部
